Sandostatin LAR Depot is a Kit in the Human Prescription Drug category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is .
| Product ID | 0078-0647_09c39d97-0b90-4a50-b3f7-ba58cc175186 |
| NDC | 0078-0647 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Sandostatin LAR Depot |
| Generic Name | Octreotide Acetate |
| Dosage Form | Kit |
| Marketing Start Date | 2015-02-01 |
| Marketing End Date | 2019-06-30 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021008 |
| Labeler Name | Novartis Pharmaceuticals Corporation |
| Active Ingredient Strength | 0 |
| NDC Exclude Flag | N |
| Marketing Start Date | 2015-02-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA021008 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2015-02-01 |
| Marketing End Date | 2019-06-30 |
| Marketing Category | NDA |
| Application Number | NDA021008 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2015-02-01 |
| Marketing End Date | 2019-06-30 |
| SPL SET ID: | d0b7fe9e-7000-4b79-ba3b-291ce92c14f9 |
| Manufacturer | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0078-0647 | Sandostatin LAR Depot | octreotide acetate |
| 0078-0648 | Sandostatin LAR Depot | octreotide acetate |
| 0078-0811 | Sandostatin LAR Depot | octreotide acetate |
| 0078-0818 | Sandostatin LAR Depot | octreotide acetate |
| 0078-0825 | Sandostatin LAR Depot | octreotide acetate |
| 0641-6174 | Octreotide Acetate | Octreotide Acetate |
| 0641-6175 | Octreotide Acetate | Octreotide Acetate |
| 0078-0180 | Sandostatin | octreotide acetate |
| 0078-0181 | Sandostatin | octreotide acetate |
| 0078-0182 | Sandostatin | octreotide acetate |
| 0078-0183 | Sandostatin | octreotide acetate |
| 0078-0184 | Sandostatin | octreotide acetate |